Cargando…

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein

Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a novel coronavirus and causing worldwide outbreaks. SARS coronavirus (SARS-CoV) is an enveloped RNA virus, which contains several structural proteins. Among these proteins, spike (S) protein is responsible fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Tin-Yun, Wu, Shih-Lu, Cheng, Shin-Ei, Wei, Yen-Chiao, Huang, Shan-Ping, Hsiang, Chien-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111049/ https://www.ncbi.nlm.nih.gov/pubmed/14706633 http://dx.doi.org/10.1016/j.bbrc.2003.11.180

Ejemplares similares

Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction
por: Ho, Tin-Yun, et al.
Publicado: (2006)

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
por: Ho, Tin-Yun, et al.
Publicado: (2007)

A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
por: Zhao, Jincun, et al.
Publicado: (2007)

The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/c mice
por: Qin, Li, et al.
Publicado: (2007)

Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus
por: Godet, Murielle, et al.
Publicado: (1991)

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
por: Woo, Patrick C.Y., et al.
Publicado: (2005)

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2018)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
por: He, Yuxian, et al.
Publicado: (2006)

The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
por: Kim, Sinae, et al.
Publicado: (2020)

Architecture of the SARS coronavirus prefusion spike
por: Beniac, Daniel R, et al.
Publicado: (2006)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Conformational Reorganization of the SARS Coronavirus Spike Following Receptor Binding: Implications for Membrane Fusion
por: Beniac, Daniel R., et al.
Publicado: (2007)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
por: Shim, Byoung-Shik, et al.
Publicado: (2010)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
por: Tian, Xiaolong, et al.
Publicado: (2020)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
por: Wang, Lin, et al.
Publicado: (2020)

Proteolysis of Sars-Associated Coronavirus Spike Glycoprotein
por: Simmons, Graham, et al.
Publicado: (2006)

Immunogenicity of a recombinant coronavirus spike glycoprotein expressed in transgenic plants
por: Escribano, J.M., et al.
Publicado: (2000)

Polymer modification of SARS-CoV-2 spike protein impacts its ability to bind key receptor
por: Sharfin Rahman, Monica, et al.
Publicado: (2023)

Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins
por: Zhou, Peng, et al.
Publicado: (2009)

A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes
por: Huang, Wei-Chiao, et al.
Publicado: (2018)

CyDisCo production of functional recombinant SARS‐CoV‐2 spike receptor binding domain
por: Prahlad, Janani, et al.
Publicado: (2021)

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding
por: Struble, Lucas R., et al.
Publicado: (2022)

Canine Enteric Coronaviruses: Emerging Viral Pathogens with Distinct Recombinant Spike Proteins
por: Licitra, Beth N., et al.
Publicado: (2014)

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
por: Hou, Yu-xuan, et al.
Publicado: (2010)

Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
por: Chuck, Chi-Pang, et al.
Publicado: (2008)

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
por: Bai, Bingke, et al.
Publicado: (2008)

Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli
por: Kim, Woo Sung, et al.
Publicado: (2022)

Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens
por: Favara, D. M., et al.
Publicado: (2020)

Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
por: Zakhartchouk, Alexander N., et al.
Publicado: (2007)

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
por: Wang, Sheng-Fan, et al.
Publicado: (2014)

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
por: Lai, Szu-Chia, et al.
Publicado: (2005)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry
por: Corver, Jeroen, et al.
Publicado: (2009)

Universal coronavirus vaccine; spike protein cloning and expression for use as a recombinant vaccine
Publicado: (1994)

Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in β-coronaviruses
por: Dong, Xuefang, et al.
Publicado: (2022)

Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core
por: Tripet, Brian, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hub25aok2rko264vgkshmvvbc9